Mayu Yamazaki‐Inoue
Papers
1
Total Citations
49
H-Index
1
About
Mayu Yamazaki‐Inoue has made pioneering contributions to regenerative medicine, focusing on the scalable production of stem cells for clinical applications. Her most-cited work, a 2013 study on automated cell processing machines, addresses a critical bottleneck in cell therapy: the transition from laboratory-scale to large-scale manufacturing. With 49 citations, this paper demonstrates her impact in solving practical challenges that have long hindered the widespread clinical adoption of stem cell therapies. By developing and validating automated systems for cell culture, Yamazaki‐Inoue has helped pave the way for reproducible, cost-effective production of therapeutic cells. Her research sits at the intersection of bioengineering and stem cell biology, where she tackles the engineering hurdles of maintaining cell quality and viability during mass production. This work is essential for researchers and clinicians aiming to bring cell-based treatments from bench to bedside, making her a key figure in the industrialization of regenerative medicine. Her achievements underscore the importance of automation in realizing the full potential of stem cell therapies for patients worldwide.
Research Focus
Key Achievements
Top Papers
- 1